Altered glutamate release in the dorsal striatum of the MitoPark mouse model of Parkinson's disease
- 1 November 2016
- journal article
- Published by Elsevier in Brain Research
- Vol. 1651, 88-94
Abstract
No abstract availableKeywords
Funding Information
- MUSC Barmore Fund
- National Institutes of Health (4R00AG033687)
This publication has 39 references indexed in Scilit:
- l-Dopa induced dyskinesias in Parkinsonian mice: Disease severity or l-Dopa historyBrain Research, 2015
- Chronic L‐DOPA induces hyperactivity, normalization of gait and dyskinetic behavior in MitoPark miceGenes, Brain and Behavior, 2015
- Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesiasParkinsonism & Related Disorders, 2014
- Astrocytic Dysfunction and AddictionThe Neuroscientist, 2014
- An update on the potential role of excitotoxicity in the pathogenesis of Parkinson's disease.2010
- MitoPark mice mirror the slow progression of key symptoms and L‐DOPA response in Parkinson's diseaseGenes, Brain and Behavior, 2010
- Metabotropic Glutamate Receptors: Physiology, Pharmacology, and DiseaseAnnual Review of Pharmacology and Toxicology, 2010
- Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neuronsProceedings of the National Academy of Sciences, 2007
- A partial GDNF depletion leads to earlier age-related deterioration of motor function and tyrosine hydroxylase expression in the substantia nigraExperimental Neurology, 2006
- Improved ceramic-based multisite microelectrode for rapid measurements of l-glutamate in the CNSJournal of Neuroscience Methods, 2002